Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Cutting-edge prevention drugs - hailed as being able to reduce new infections to zero - could see the end of the Aids ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment.

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

A single dose of a four-drug combination therapy for uncomplicated malaria was just as effective as the multi-day standard of ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...